NO20070457L - Pyrazolderivater - Google Patents
PyrazolderivaterInfo
- Publication number
- NO20070457L NO20070457L NO20070457A NO20070457A NO20070457L NO 20070457 L NO20070457 L NO 20070457L NO 20070457 A NO20070457 A NO 20070457A NO 20070457 A NO20070457 A NO 20070457A NO 20070457 L NO20070457 L NO 20070457L
- Authority
- NO
- Norway
- Prior art keywords
- group
- substituted
- groups
- formula
- halogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det beskrives en forbindelse representert ved formel (I): (hvor Ar1 representerer en fenylgruppe som kan ha 1 til 3 substituenter eller en usubstituert 5- eller 6-leddet aromatisk heterocyklisk gruppe; Ar2 representerer (i) en usubstituert fenylgruppe, (ii) en fenylgruppe som er substituert med en lavere alkylgruppe som har 1 til 3 grupper eller atomer valgt blant en karbamoylgruppe, en aminogruppe, en hydroksylgruppe, en lavere alkoksygruppe og et halogenatom, eller (iii) en 5- eller 6-leddet nitrogenholdig aromatisk heterocyklisk gruppe som er substituert med 1 til 3 grupper eller atomer valgt blant en lavere alkylgruppe, en lavere alkynylgruppe, en lavere alkanoylgruppe, en karbamoylgruppe, en cyanogruppe, en aminogruppe, en hydroksylgruppe, en lavere alkoksygruppe og et halogenatom; og X representerer en gruppe representert ved formel (II): [F2] (hvor ringstrukturen representerer en 4- til 7-leddet heterocyklisk gruppe som i tillegg til nitrogenatomet vist i formel (II), kan ha ett heteroatom valgt blant nitrogen, oksygen og svovel, og som kan være substituert med 1 til 4 grupper eller atomer valgt blant en lavere alkylgruppe, en karbamoylgruppe, en aminogruppe, en hydroksylgruppe, en lavere alkoksygruppe, en oksogruppe, en lavere alkanoylgruppe, en lavere alkylsulfonylgruppe og et halogenatom", et salt derav eller et solvat av forbindelsen eller saltet, og et medikament.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004195497 | 2004-07-01 | ||
| PCT/JP2005/012176 WO2006004027A1 (ja) | 2004-07-01 | 2005-07-01 | ピラゾール誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20070457L true NO20070457L (no) | 2007-01-24 |
Family
ID=35782831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20070457A NO20070457L (no) | 2004-07-01 | 2007-01-24 | Pyrazolderivater |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080064682A1 (no) |
| EP (1) | EP1762568A1 (no) |
| JP (1) | JPWO2006004027A1 (no) |
| CN (1) | CN1980912A (no) |
| AU (1) | AU2005258397A1 (no) |
| CA (1) | CA2572163A1 (no) |
| IL (1) | IL180044A0 (no) |
| MX (1) | MX2007000016A (no) |
| NO (1) | NO20070457L (no) |
| RU (1) | RU2007103831A (no) |
| TW (1) | TW200613297A (no) |
| WO (1) | WO2006004027A1 (no) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101001852A (zh) * | 2004-08-06 | 2007-07-18 | 第一制药株式会社 | 吡唑衍生物 |
| JP2009184925A (ja) * | 2006-11-02 | 2009-08-20 | Dai Ichi Seiyaku Co Ltd | ５−（１ｈ−１，２，３−トリアゾール−４−イル）−１ｈ−ピラゾール誘導体 |
| US7977358B2 (en) * | 2007-07-26 | 2011-07-12 | Hoffmann-La Roche Inc. | Pyrazol derivatives |
| DE102008015032A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte Pyrazolamide und ihre Verwendung |
| DE102008015033A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| US8563001B2 (en) * | 2008-11-05 | 2013-10-22 | Regents Of The University Of Minnesota | Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease |
| DE102008062863A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiophenyl-carbonyl)imidazolidinone und ihre Verwendung |
| DE102008062878A1 (de) | 2008-12-17 | 2010-06-24 | Aicuris Gmbh & Co. Kg | Substituierte Furancarboxamide und ihre Verwendung |
| DE102009036604A1 (de) | 2009-07-30 | 2011-02-03 | Aicuris Gmbh & Co. Kg | Substituierte Bis-Arylpyrazolamide mit terminaler primärer Amidfunktionalisierung und ihre Verwendung |
| EP2585453A4 (en) * | 2010-06-28 | 2014-10-22 | Harvard College | COMPOUNDS FOR INHIBITING CELL PROLIFERATION |
| DE102011055815A1 (de) | 2011-11-29 | 2013-05-29 | Aicuris Gmbh & Co. Kg | Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung |
| DE102012016908A1 (de) | 2012-08-17 | 2014-02-20 | Aicuris Gmbh & Co. Kg | Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung |
| US9273067B2 (en) * | 2014-02-19 | 2016-03-01 | Bristol-Myers Squibb Company | Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication |
| EP3241830A1 (de) | 2016-05-04 | 2017-11-08 | Bayer CropScience Aktiengesellschaft | Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel |
| CN109270054A (zh) * | 2018-04-13 | 2019-01-25 | 宁夏医科大学 | 一种羟胺三氯化铁法测定人血清胆碱酯酶方法 |
| CN109970648B (zh) * | 2019-03-25 | 2022-05-20 | 西华大学 | 脒及其类似物催化二氮杂脂肪环叔丁氧羰基单保护方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| DE10152005A1 (de) * | 2001-10-22 | 2003-04-30 | Bayer Cropscience Ag | Pyrazolylsubstituierte Heterocyclen |
| KR20050083761A (ko) * | 2002-12-02 | 2005-08-26 | 후지사와 야꾸힝 고교 가부시키가이샤 | Ｃｏｘ－ｉ저해제로서 유용한 피라졸 유도체 |
| EP1591443B1 (en) * | 2003-02-07 | 2010-08-25 | Daiichi Sankyo Company, Limited | Pyrazole derivative |
| WO2004094407A1 (ja) * | 2003-04-21 | 2004-11-04 | Daiichi Pharmaceutical Co. Ltd. | ５員複素環誘導体 |
| TW200526588A (en) * | 2003-11-17 | 2005-08-16 | Smithkline Beecham Corp | Chemical compounds |
| JP2008513426A (ja) * | 2004-09-20 | 2008-05-01 | バイオリポックス エービー | 炎症の治療に有用なピラゾール化合物 |
| CA2630269C (en) * | 2005-11-28 | 2011-07-05 | F. Hoffmann-La Roche Ag | Inhibitors of diacyglycerol acyltransferase (dgat) |
| EP1983971A4 (en) * | 2006-01-25 | 2010-11-24 | Synta Pharmaceuticals Corp | SUBSTITUTED AROMATIC COMPOUNDS FOR USE AGAINST INFLAMMATION AND IMMUNE DISORDERS |
-
2005
- 2005-07-01 WO PCT/JP2005/012176 patent/WO2006004027A1/ja not_active Ceased
- 2005-07-01 MX MX2007000016A patent/MX2007000016A/es unknown
- 2005-07-01 TW TW094122375A patent/TW200613297A/zh unknown
- 2005-07-01 AU AU2005258397A patent/AU2005258397A1/en not_active Abandoned
- 2005-07-01 CA CA002572163A patent/CA2572163A1/en not_active Abandoned
- 2005-07-01 CN CNA2005800222097A patent/CN1980912A/zh active Pending
- 2005-07-01 RU RU2007103831/04A patent/RU2007103831A/ru unknown
- 2005-07-01 US US11/571,387 patent/US20080064682A1/en not_active Abandoned
- 2005-07-01 JP JP2006528842A patent/JPWO2006004027A1/ja not_active Withdrawn
- 2005-07-01 EP EP05755841A patent/EP1762568A1/en not_active Withdrawn
-
2006
- 2006-12-13 IL IL180044A patent/IL180044A0/en unknown
-
2007
- 2007-01-24 NO NO20070457A patent/NO20070457L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20080064682A1 (en) | 2008-03-13 |
| IL180044A0 (en) | 2007-05-15 |
| CN1980912A (zh) | 2007-06-13 |
| RU2007103831A (ru) | 2008-08-10 |
| WO2006004027A1 (ja) | 2006-01-12 |
| EP1762568A1 (en) | 2007-03-14 |
| AU2005258397A1 (en) | 2006-01-12 |
| CA2572163A1 (en) | 2006-01-12 |
| MX2007000016A (es) | 2007-03-27 |
| JPWO2006004027A1 (ja) | 2008-04-24 |
| TW200613297A (en) | 2006-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20070457L (no) | Pyrazolderivater | |
| WO2005037781A3 (fr) | Derives de n-[heteroaryl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique | |
| NO20053974L (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
| NO20081464L (no) | 1-heterocyklusulfonyl, 2-aminometyl, 5-(hetero-)aryl subsidiert 1-H-pyrrol-derivater som syresekresjonsinhibitorer | |
| WO2003057688A3 (en) | Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators | |
| EP1724262A4 (en) | 1- (2H) -ISOCHINOLONDERIVAT | |
| DK1414302T3 (da) | 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe | |
| EA200601235A1 (ru) | Производные тиазола | |
| NO20062633L (no) | Pyrazolderivater som proteinkinasemodulatorer | |
| EA200400452A1 (ru) | Производные 3-замещенных 4-пиримидонов | |
| AR018452A1 (es) | Compuestos antibioticos de oxazolidinona sustituida, proceso para su preparacion, metodo para producir un efecto antibacteriano, composicionesfarmaceuticas que los contienen y su uso para preparar medicamentos | |
| EA200401613A1 (ru) | Лекарственное средство для лечения рака | |
| WO2008078196A3 (en) | Substituted heteroaryl pyridopyrimidone derivatives | |
| NO20081551L (no) | Heterocyklisk substituerte pyridinderivater og antisoppmidler inneholdende samme | |
| ECSP045359A (es) | Isoxazolinas 5 metiloximetil sustituidas por 3-heteroarilo utilizadas con herbicidas | |
| NO20074763L (no) | (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi | |
| WO2008155668A3 (en) | Heteroarylamide pyrimidone compounds | |
| EA200401615A1 (ru) | ИНГИБИТОРЫ АКТИВАЦИИ NF-kB | |
| NO20064297L (no) | Aminoalkoholforbindelse | |
| NO20063090L (no) | Amidopyrazolderivater | |
| NO20055921L (no) | Heterocykliske metylsulfonderivater | |
| DE602004020730D1 (de) | Pharmazeutisches verfahren und damit hergestellte verbindungen | |
| KR930004262A (ko) | 메타노안트라센 화합물 | |
| NO20063330L (no) | Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer | |
| ATE274518T1 (de) | 6-(2-chlor-6-fluor-phenyl)-triazolpyrimidine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |